Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADCTA-G Adjuvant Immunotherapy for Glioblastoma
NCT02772094Phase 2Unknown
- Sponsor
- China Medical University Hospital
- Start
- May 2005
- Primary completion
- Dec 2014
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of ADCTA-G in glioblastoma multiforme (GBM), sponsored by China Medical University Hospital. Status: unknown.
02
Drugs
ADCTA-G
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT02772094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02772094.